Significant dose-dependent reduction in neurofilament light chain concentration in plasma with oral tau aggregation inhibitor hydromethylthionine mesylate
Wischik, C. M., Schelter, B., Penny, L. K., Miller, S., Stefanacci, R., Heslegrave, A., Zetterberg, H.
In vivo ultrafast Doppler imaging combined with confocal microscopy and behavioral approaches to gain insight into the central expression of Peripheral Neuropathy in Trembler-J Mice
Martínez Barreriro, M., Vázquez Alberdi, L., De León, L., Avellana, G., Duarte, A., Fialho, M. A., Baranger, J., Calero, M., Rubido, N., Tanter, M., Negreira, C., Brum, J., Damián, J. P., Kun, A.
Ethnic differences in the indirect effects of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: a population-based, observational cohort study using the OpenSAFELY platform
Costello, R. E., Tazare, J., Herrett, E., Parker, E. P., Zheng, B., Mansfield, K. E., Henderson, A. D., Carreira, H., Bidulka, P., Wong, A. Y., Warren-Gash, C., Eggo, R. M., Tomlinson, L., Langan, S. M., Mathur, R., Piehlmaier, D., MacKenna, B., Mehrkar, A., Piehlmaier, D., Hayes, J. F., Quint, J. K., Katikireddi, S. V., Mathur, R., Chaturvedi, N., Park, C., Carnemolla, A., Williams, D., Knueppel, A., Boyd, A., Turner, E. L., Evans, K. M., Thomas, R., Berman, S., McLachlan, S., Crane, M., Whitehorn, R., Oakley, J., Foster, D., Mitchell, R., Booth, C., Kennedy, J., Wright, J., Yang, T., Shah, S. A., Kopasker, D., Hughes, A., Perez-Reche, F., Smith, R. M., Brown, A. D., Harrison, D., The OpenSAFELY collaborative, LH&W NCS (or CONVALESCENCE) Collaborative
Volpe, G., Maragò, O. M., Rubinsztein-Dunlop, H., Pesce, G., Stilgoe, A. B., Volpe, G., Tkachenko, G., Truong, V. G., Chormaic, S. N., Kalantarifard, F., Elahi, P., Käll, M., Callegari, A., Marqués, M. I., Neves, A. A. R., Moreira, W. L., Fontes, A., Cesar, C. L., Saija, R., Saidi, A., Beck, P., Eismann, J. S., Banzer, P., Fernandes, T. F. D., Pedaci, F., Bowen, W. P., Vaippully, R., Lokesh, M., Roy, B., Thalhammer-Thurner, G., Ritsch-Marte, M., García, L. P., Arzola, A. V., Castillo, I. P., Argun, A., Muenker, T. M., Vos, B. E., Betz, T., Cristiani, I., Minzioni, P., Reece, P. J., Wang, F., McGloin, D., Ndukaife, J. C., Quidant, R., Roberts, R. P., Laplane, C., Volz, T., Gordon, R., Hanstorp, D., Marmolejo, J. T., Bruce, G. D., Dholakia, K., Li, T., Brzobohatý, O., Simpson, S. H., Zemánek, P., Ritort, F., Roichman, Y., Bobkova, V., Wittkowski, R., Denz, C., Kumar, G. V. P., Foti, A., Donato, M. G., Gucciardi, P. G., Gardini, L., Bianchi, G., Kashchuk, A. V., Capitanio, M., Paterson, L., Jones, P. H., Berg-Sørensen, K., Barooji, Y. F., Oddershede, L. B., Pouladian, P., Preece, D., Adiels, C. B., Luca, A. C. D., Magazzù, A., Ciriza, D. B., Iatì, M. A., Swartzlander, G. A.
Counting the Acid Sites in a Commercial ZSM-5 Zeolite Catalyst
Zachariou, A., Hawkins, A. P., Howe, R. F., Skakle, J. M. S., Barrow, N., Collier, P., Nye, D. W., Smith, R. I., Stenning, G. B. G., Parker, S. F., Lennon, D.
ACS physical chemistry Au, vol. 3, no. 1, pp. 74-83
Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate
Wischik, C. M., Bentham, P., Gauthier, S., Miller, S., Kook, K., Schelter, B. O.
Journal of Prevention of Alzheimer's Disease, vol. 9, pp. 780-790
Migrating Thermal Tides in the Martian Atmosphere During Aphelion Season Observed by EMM/EMIRS
Fan, S., Forget, F., Smith, M. D., Guerlet, S., Badri, K. M., Atwood, S. A., Young, R. M., Edwards, C. S., Christensen, P. R., Deighan, J., Al Matroushi, H. R., Bierjon, A., Liu, J., Millour, E.
Geophysical Research Letters, vol. 49, no. 18, e2022GL099494